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Abstract 
In this paper, we discuss the impact of some mortality data anomalies on an internal model capturing longevity 
risk in the Solvency 2 framework. In particular, we are concerned with abnormal cohort effects such as those 
for generations 1919 and 1920, for which the period tables provided by the Human Mortality Database show 
particularly low and high mortality rates respectively. To provide corrected tables for the three countries of 
interest here (France, Italy and West Germany), we use the approach developed by Boumezoued (2016) for 
countries for which the method applies (France and Italy), and provide an extension of the method for West 
Germany as monthly fertility histories are not sufficient to cover the generations of interest. These mortality 
tables are crucial inputs to stochastic mortality models forecasting future scenarios, from which the extreme 
0,5% longevity improvement can be extracted, allowing for the calculation of the Solvency Capital Requirement 
(SCR). More precisely, to assess the impact of such anomalies in the Solvency II framework, we use a simplified 
internal model based on three usual stochastic models to project mortality rates in the future combined with a 
closure table methodology for older ages. Correcting this bias obviously improves the data quality of the 
mortality inputs, which is of paramount importance today, and slightly decreases the capital requirement. 
Overall, the longevity risk assessment remains stable, as well as the selection of the stochastic mortality model. 
As a collateral gain of this data quality improvement, the more regular estimated parameters allow for new 
insights and a refined assessment regarding longevity risk. 
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1. Introduction 
 
In this paper, our aim is to discuss and assess the impact of anomalies in national mortality tables provided by 
the Human Mortality Database3 on the internal model of a typical insurer which captures longevity risk in the 
Solvency 2 framework. Of special interest in this paper are some abnormal cohort effects observed on period 
tables in which some diagonals show special patterns. Particular attention is devoted to the 1919-1920 effect: 
the 1919 diagonal shows particularly low mortality rates, whereas the 1920 generation shows particularly high 
ones. This effect can be easily observed using matrices of mortality improvements by age and time, on which 
clear diagonal effects appear, or by comparing the mortality rates of the generations considered, see the 
example of France in Figure 1. 
 
Figure 1 - Abnormal cohort effects: example of the period table for France  
Such results are counter-intuitive regarding natural demographic insight: some populations born more recently 
live less longer in average (see again Figure 1), as it is indeed observed that the “younger” generation 1920 
shows higher mortality rates in the period table. 
In the actuarial literature, few references have been focusing on mortality data reliability. The awareness about 
such anomalies has recently emerged from the work by Richards (2008), Cairns et al. (2016) and Boumezoued 
(2016) (see also Boumezoued & Devineau (2017)). To our knowledge, the first conjecture about the potential 
causes of these isolated cohort effects was by Richards (2008). He focused on the 1919 birth cohort for England 
& Wales for which he suggested the possibility of errors due to erratic number of births. Such conjecture took a 
concrete form as the ONS (Office for National Statistics) produced corrected tables, in fact a mortality increase 
for this 1919 cohort, particularly at high ages. The ONS methodology has then been studied by Cairns et al. 
(2016) in several directions, who proposed an approach whose scope was to correct the mortality table of 
England & Wales. Then, Boumezoued (2016) underlined the universality of such anomalies (isolated cohort 
effects) by highlighting them in a variety of countries from the Human Mortality Database (HMD). By studying 
the HMD methodology to construct period tables, he proposed to source its fertility counterpart, the Human 
                                                                
3 Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for 
Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de. It is worth 
mentioning that at the time of writing, the Human Mortality Database released an update on February 2018, 
including in particular a revision of exposure calculation based on monthly birth counts. We refer the reader to 
the Version 6 of the HMD Methods Protocol for more details. 
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Fertility Database (HFD), and to apply the philosophy of the work by Cairns et al. (2016) to produce corrected 
period mortality tables for a set of countries. 
In this paper, we discuss the impact of some mortality data anomalies on the longevity risk module of an 
internal model in the framework of Solvency 2, and in particular on trend risk which can be defined as the risk 
that the trend driving the future longevity evolution may experience unexpected changes. The three countries 
of interest in this paper are France, Italy and West Germany, due to their business exposure, and as they have 
been identified as embedding anomalies in their HMD mortality data. By applying and extending the correction 
methodology as described in Boumezoued (2016), we are able to measure the discrepancy between original 
and corrected period mortality tables. These discrepancies are crucial in the way the insurance market 
measures and manages longevity risk, especially in the present context. 
Among life risks modules, one of the most important risks threatening insurers is longevity risk, which is the 
risk that insured people may on average survive longer than expected. The longevity exposure is the result of 
long term commitments (up to 60 years) with high uncertainties in the mid-term (10-20 years). Several decades 
and therefore several generations of contracts might be necessary before detecting any risk deviation. There is 
no consensus on the future evolution of longevity, either in terms of model or market price. Many 
interconnected factors are to be considered in the future longevity trend, as for example technological 
improvements, socio-economic trends, political systems, demographic structures. While some experts consider 
that the human being has already reached its maximum age, others dream of immortality thanks to 
transhumanism. Facing with such uncertainty, preparing insurance companies for aging issues and its business 
consequences is fundamental. 
As a reminder, the Solvency II Directive became fully applicable on 2016, January 1st. Solvency II reviews the 
prudential regime for insurance and reinsurance undertakings in the European Union in a harmonized 
prudential framework. The risk profile of each individual insurance company is further considered, with the aim 
to promote comparability, transparency and competitiveness. The Solvency II Directive provides two ways of 
measuring risk: insurance and reinsurance companies can use either the standard formula or their own internal 
model, which enables them to assess their own risk more accurately. In the framework of the Standard 
Formula, a risk classification is provided, which includes risk modules (such as market risks, life risks, non-life 
risks) and risk sub modules (such as mortality, longevity, lapse, CAT, etc. for life risks module). For each sub 
module, a stress test or a closed formula is used to determine a capital charge. The capital requirement is then 
calculated using a bottom-up approach, by aggregating submodules and then modules based on a correlation 
matrix. In comparison, the development of an internal model allows the company to refine its own risk 
assessment. In particular regarding life risks, the company has the possibility to use external data which reflects 
its risk in terms of countries considered, such as general population tables as provided by the Human Mortality 
Database for more than thirty countries and regions worldwide. It is the purpose of the present paper to 
identify, correct and test the impact of anomalies in national general population tables as key inputs in the 
internal model. 
It is worth mentioning that the longevity shocks calibration for the Standard Formula has resulted from the 
comparison of retrospective and prospective analyses, see the CEIOPS’ A vice for Leve  2 Imp ementing 
Measures on Solvency II, especially the Annex B “Longevity risk ca ibration ana ysis”. More specifically, two 
analyses have been conducted: the first one focusing on past historical mortality improvements, the second 
one generating shocks in the future. It has been concluded that the direct use of historical data led to a higher 
longevity stress compared to that derived from the forecasts of a stochastic model. In the same spirit, a 
prospective and retrospective analysis has been derived by Boumezoued (2016) on both crude and corrected 
mortality data; the analysis of corrected mortality tables showed that, not only the mortality levels for several 
cohorts were highly over/under-estimated, but also that the volatility of mortality improvement rates over the 
last 30 years was over-estimated in original HMD mortality tables, with a large difference for many countries. In 
addition, it has been shown how the volatility levels reproduced by classical stochastic mortality models now 
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closely match historical mortality improvements in corrected tables, although it was not the case on crude data 
as pointed out by several studies as cited before. 
The previous considerations illustrate the potential impact of such mortality data correction on several steps of 
internal modelling process. To assess the business impact of such a complex risk, we use in this paper a 
simplified internal model specification. Market practices rely on two main classes of stochastic mortality 
models: the first class regroups models derived from Lee-Carter approach while the second class of models is 
derived from Cairns, Black and Dowd approach. Usually calibrated on national mortality tables, such models 
have proven their ability to capture historical mortality behaviors. However, a core issue is their sensitivity to 
possible singularities or anomalies in the underlying mortality data. 
In this paper, a simplified prototype of internal model is used and embeds the following features: a set of 
mortality models is fitted based on national population mortality data, an  the ‘best’ mo e  is se ecte  base  
on statistical and qualitative criteria. The selected mortality model is then used to draw simulated forecasts, 
and a prospective mortality table corresponding to the 99.5 percentile in terms of improvements is built. This 
allows to provide the longevity shock at the core of the Solvency II economic capital calculation, here based on 
an annuity product portfolio. 
The paper is organized as follows. Section 2 deals with the mortality data anomalies and focuses on the 
methodologies to detect and correct them, as well as on the key characteristics of corrected mortality tables. 
This includes the use of the method developed by Boumezoued (2016) to correct period tables for Italy and 
France, and the novel approach we propose in order to correct the West Germany mortality table, for which 
fertility histories are not sufficient to cover the 1919-1920 generations of interest. In Section 3, we introduce 
the stylized internal model which is used to calculate the Solvency Capital Requirement associated with 
longevity risk, and the impact of the mortality data anomalies on the internal model in the light of several 
analyses; in particular, we discuss the way it impacts the fit of stochastic mortality models, the future forecasts, 
the model selection process, the calculation of the SCR, as well as the stability of longevity risk assessment. The 
paper ends with some concluding remarks in Section 4. 
2. Mortality data reliability issues  
 
In this section, we focus on the identification and correction of several anomalies in mortality tables obtained 
from the Human Mortality Database for our three countries of interest: France, Italy and West Germany. After 
highlighting the recent awareness on such anomalies in the literature a well as the key observations on the 
crude datasets, we detail the correction methodologies we use and we describe the main characteristics of 
corrected mortality tables. 
2.1. On the recent awareness about anomalies in mortality tables 
 
As mentioned in the Introduction, few actuarial work has been focusing on mortality data reliability, but the 
awareness about such anomalies have recently emerged from the work by Richards (2008), Cairns et al. (2016) 
and Boumezoued (2016). The last author put into evidence the universality of such anomalies (isolated cohort 
effects) by highlighting them in a variety of countries from the Human Mortality Database (HMD). By studying 
the HMD methodology to construct period tables, he proposed to source its fertility counterpart, the Human 
Fertility Database (HFD), and to apply the philosophy of the work by Cairns et al. (2016) to produce corrected 
period mortality tables for a set of countries. 
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In this paper, we apply and extend the correction methodology as described in Boumezoued (2016). This way, 
we are able to measure the discrepancy between original and corrected period mortality tables, which are 
crucial inputs for the measurement and management of longevity risk in the insurance market. 
In order to present the up-to-date awareness on such abnormal cohort effects, we summarize below the main 
conclusions from the work of Boumezoued (2016): 
1. While comparing period and cohort mortality tables, anomalies in period ones have been highlighted in the 
form of isolated cohort effects for several countries available in HMD: the period mortality rates for specific 
generations appear surprisingly low or high compared to the others. 
2. The HMD methodology to construct mortality estimates has been identified to embed a strong assumption 
of uniform distribution of births that is specific to the computation of period mortality tables, which shows that 
we are facing a universal reliability issue which is shared by most countries. 
3. To perform an automatic correction procedure, it is proposed to rely on the Human Fertility Database (HFD), 
which is considered as the perfect counterpart of the HMD in terms of fertility. 
4. The analysis of corrected mortality tables for several countries led to the conclusion that isolated cohort 
effects” in origina  morta ity tab es (often for years of birth around 1915, 1920, 1940 and 1945) are in fact 
universal anomalies that disappear in corrected tables. Further analysis of corrected mortality tables show that, 
not only the mortality levels for several cohorts are highly over/under-estimated, but also that the volatility of 
mortality improvement rates over the last 30 years was over-estimated in original HMD mortality tables, with a 
large difference for many countries. 
In the next part 2.2, we detail the correction methodology based on fertility data which is used in the present 
paper to correct mortality tables for France and Italy. In the subsequent part 2.3, we motivate the need for an 
extension of the methodology and we propose a novel approach to produce a corrected table for West 
Germany. Finally, subsection 2.4 details the main characteristics of the corrected mortality tables and the key 
discrepancies with the original data.  
As a final remark, let us emphasize that two kinds of mortality tables are provided by the Human Mortality 
Database: period and cohort. Anomalies in terms of abnormal cohort effects have been identified in period 
mortality tables, which are naturally designed to study the dynamics of mortality from one year to the next, 
and therefore systematically used in practice to calibrate stochastic mortality models. For a review of the 
definition and construction methods for period and cohort tables, see Boumezoued (2016).  
2.2. The correction method based on fertility data 
 
In practice, period mortality tables for one-year time periods and one-year age classes are produced based on 
annual population estimates derived from census, as well as number of deaths combining the information of 
death reports and population counts. Note that in most countries, census may be performed out of the 
beginning of the year, or at intervals greater than one year, which leads the HMD to perform several 
adjustments, see Wilmoth et al. (2007) for more details. In our framework however, we assume that input data 
provided by the HMD as annual population counts and number of deaths in Lexis triangles are accurate.  
Two ingredients are at the core of death rate computation for a given period: the number of deaths in this 
period, which we assumed to be reliable, divided by the so-ca  e  “exposure-to-risk” which represents the 
“quantity” of in ivi ua s at risk of  eath. In so-called period mortality tables, the exposure-to-risk takes the 
mathematical form of an integral over a one-year time period and a one-year age-class, see Boumezoued 
(2016) for more details on the formalism. In this setting the period mortality rate writes 
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𝑚(𝑥, 𝑡) =
𝐷(𝑥, 𝑡)
𝐸(𝑥, 𝑡)
, 
where 𝐷(𝑥, 𝑡) is the number of deaths and 𝐸(𝑥, 𝑡) the total time lived in the year [𝑡, 𝑡 + 1) at age between 𝑥 
and 𝑥 + 1. The mortality rate is the core object to be modelled by stochastic mortality models, as it is also the 
case for the death probability 𝑞(𝑥, 𝑡), more interpretable as the probability for individuals aged 𝑥 at time 𝑡 to 
die in the next year, and linked to the mortality rates through the following equation: 
𝑞(𝑥, 𝑡) = 1 − exp(−𝑚(𝑥, 𝑡)). 
In the standard computation practice, the exposure-to-risk component 𝐸(𝑥, 𝑡) is usually approximated based 
on annual population estimates, as it is done by reference providers as national institutes or the Human 
Mortality Database. In other words, the standard practice works with the average between the population at 
the beginning of the year and that at the end of the year, which is taken as a proxy for the integral over the 
year in continuous time. This computation amounts to assume that births are uniformly distributed in the year, 
as well as from one cohort to the next. 
Although for several years where population flows are quite stable the assumption may seem reasonable 
(although not perfect), the approximation error can be huge in situations in which population numbers are 
fluctuating in the year, that is particularly the case when births are erratic due to demographic shocks (e.g. 
before an  after wars an  pan emics). Such specific patterns create a “convexity effect”, an  in this context it 
is no longer possible to approximate the exposure-to-risk by a standard average. 
To correct for such approximation errors for countries available in the Human Mortality Database, the 
approach proposed by Boumezoued (2016) relies on monthly fertility records available from the Human 
Ferti ity Database. Such month y popu ation estimates are use  to construct a “ ata qua ity in icator” assessing 
the reliability of estimates in the (period) mortality table for each generation. The indicator takes the form of a 
ratio which measures the deviation between an annual and a monthly approximation of the (annual) exposure-
to risk. For each year of birth, this ratio is then used to adjust the estimates along each diagonal of the 
mortality table (that is following each cohort), producing a corrected table which does not present the initial 
anomalies. 
In this latter work, corrected period tables have been provided for France, Switzerland, Finland, Sweden and 
Austria, countries for which complete and deep fertility histories were available at time of publication. 
Meanwhile, the monthly fertility data for Italy has been officially released by the Human Fertility Database, 
allowing us to use the same methodology for this country as well. Note also that this is the case of Iceland, 
which will be added to the set of explanatory countries for West Germany, see the next subsection c). In the 
following, we present the results in terms of correction indicator for France and Italy; the specific treatment of 
West Germany, for which the monthly fertility history is not deep enough, is detailed in the next part c). The 
key characteristics of corrected period tables are then described in the last part d) of this section. 
The number of births by months as well as the correction indicator computed for France and Italy using the 
method by Boumezoued (2016) are depicted in Figure 2. This figure shows how shocks in birth patterns impact 
the exposure-to-risk approximation as it is performed in period tables provided by the HMD. The virtue of the 
correction indicator appears from these graphs: for a given year of birth, a value greater (resp. lower) than one 
indicates that the HMD period mortality rates for the generation are over-estimated (resp. under-estimated). In 
addition, the ratio measures the magnitude of the discrepancy between the annual exposure-to-risk 
approximation and its (better) monthly counterpart. It should be noted that although the dynamics of the 
number of births over the months differs between France and Italy, the 1919-1920 effect shows some 
universality: the period mortality rates for generation 1919 are under-estimated, whereas those for generation 
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1920 are over-estimated. Moreover, in each case the order of magnitude of the error is +/-6%, see again Figure 
2; this may represent a level of particular attention for practitioners using national mortality data. 
 
 
Figure 2 - Number of births by months and correction indicator for France and Italy 
 
2.3. An extension of the correction method for West Germany 
 
As mentioned in the previous part, in its present form the correction methodology can only be applied to years 
of birth for which the number of births by months are provided by the Human Fertility Database. 
Unfortunately, this is not the case for West Germany for which the HFD monthly fertility records are provided 
starting at year 1946, which consequently limits the set of years of birth for the correction ratio, see Figure 3.  
 
Figure 3 - Number of births by months and correction indicator for West Germany 
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Therefore, there is a need to extend the previous methodology to enable producing an output corrected table, 
especially for the typical 1919-1920 phenomenon which, again, lies outside of the historical period. 
Regression with stepwise selection process 
The idea now is to try to reconstruct the fertility history for West Germany, by looking at that other countries 
for which the birth series are available. Although number of births show clear different patterns from one 
country to another, (see Figure 2 in the previous part b), as well as Figure 9 in Boumezoued (2016)) the 
correction indicator, as a quantity without dimension (ratio of population estimates), shows quite similar 
patterns among the several countries. 
To infer the correction indicator for West Germany starting from that of other countries, we propose to use a 
multiple regression approach, while performing an optimal selection procedure. In order to properly detail the 
regression and prediction methodology, let us introduce some notations. We denote by 𝐼𝐶(𝑡) the correction 
indicator available for country 𝐶 and year-of-birth 𝑡. The set of countries for which reasonable monthly fertility 
series are now available is set as 
𝒮 = {Finland, France, Iceland, Italy, Sweden, Switzerland}. 
This set is selected in order to satisfy the two following criteria: 
• Data on births by months is officia  y re ease  by the HFD (i.e. not state  as “pre iminary re ease”), to 
avoid any major data issue on birth series, 
• The monthly fertility series allow constructing correction indicators for years of birth before 1914, 
which covers the 1919-1920 effect with margin. 
The aim now is to find an optimal set of regressors 𝒮∗ ⊂ 𝒮, and coefficients {𝛼𝐶 , 𝐶 ∈ 𝒮
∗} and 𝜇 such that  
𝐼𝑊𝑒𝑠𝑡 𝐺𝑒𝑟𝑚𝑎𝑛𝑦(𝑡) = 𝜇 + ∑ 𝛼𝐶  𝐼𝐶(𝑡)
𝐶∈𝒮∗
, 
for each 𝑡 such as the indicator for West Germany 𝐼𝑊𝑒𝑠𝑡 𝐺𝑒𝑟𝑚𝑎𝑛𝑦(𝑡) can be constructed, that is here for each 
year of birth 𝑡 between 1947 and 2010 (2010 being chosen as an upper bound for all countries in order to avoid 
depending on recent revisions of demographic data). 
Results of the regression and prediction of the correction indicator 
The method carried out is a step-by-step comparison of the models obtained as a combination of regressors 
from the set 𝒮. At this stage, a statistical criterion has to be specified in order to compare models; we tested 
the classical criteria BIC and Adjusted R-square, both providing some penalization of the fitting ability of the 
model by the number of parameters. The resu ts in terms of “best” mo e  selected and associated parameter 
values are presented in the table below (rounded at 2 significant numbers). 
 BIC Adjusted R-squared 
𝒮∗ {𝐹𝑖𝑛𝑙𝑎𝑛𝑑, 𝐹𝑟𝑎𝑛𝑐𝑒} {𝐹𝑖𝑛𝑙𝑎𝑛𝑑, 𝐹𝑟𝑎𝑛𝑐𝑒, 𝐼𝑡𝑎𝑙𝑦} 
?̂? -0.19 -0.14 
?̂?𝐹𝑖𝑛𝑙𝑎𝑛𝑑   0.38 0.21 
?̂?𝐹𝑟𝑎𝑛𝑐𝑒  0.81 0.63 
?̂?𝐼𝑐𝑒𝑙𝑎𝑛𝑑  X X 
?̂?𝐼𝑡𝑎𝑙𝑦 X 0.29 
?̂?𝑆𝑤𝑒𝑑𝑒𝑛  X X 
?̂?𝑆𝑤𝑖𝑡𝑧𝑒𝑟𝑙𝑎𝑛𝑑  X X 
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Interestingly, the results show strong similarities between the BIC and the R-squared criteria. In particular, in 
each case the “best” mo e  inc u es Fin an  an  France as pre ictors of West Germany, a though the Adjusted 
R-squared criterion also includes Italy. Another interesting feature is that the three countries of interest here, 
which have been identified to embed strong 1919-1920 anomalies, are linked with each other (with the 
Adjusted R-squared criterion), France and Italy being key predictors for West Germany. In terms of parameters, 
significant weight is given to France correction ratio as an explanatory variable in each case. 
At this stage, empirical expert judgement has to be used to define the final choice between both criteria; in this 
paper, we choose the results given by the R-squared adjustments having in mind the three following 
arguments: 
• It is preferred to use more series to increase stability, therefore to include Italy as well, as we consider 
it as a good input to explain fertility shocks in West Germany, 
• The output corrected table for West Germany according to the R-squared criterion, see the next part 
d), shows graphically even less isolated cohort trends than that produced according to the BIC 
criterion, 
• On the whole, both criteria (BIC or R-squared) provide similar results in terms of residuals, correction 
indicator series and output corrected tables. 
Prediction of the correction indicator 
For birth years outside the range of the correction indicator availability for West Germany, that is for 𝑡 before 
1946, the true indicator 𝐼(𝑡) can be predicted by its estimate 𝐼(𝑡) according to the regression formula 
𝐼𝑊𝑒𝑠𝑡 𝐺𝑒𝑟𝑚𝑎𝑛𝑦(𝑡) = ?̂? + ∑ ?̂?𝐶  𝐼𝐶(𝑡)
𝐶∈𝒮∗
 
The reconstructed correction indicator is depicted in Figure 4. The key fact which appears from the observation 
of the reconstructed correction ratio is the following: although almost no spikes were observed in the available 
period for regression (plain line), the use of external data allows us to reproduce the generational fertility 
shocks at the core times in history (including around 1915 and around 1920) – this good feature captured here 
lies in the universality of the abnormal cohort countries in the selected regressors. 
The correction efficiency of the regression approach presented here will be evaluated in the next part d) in 
which we analyze the main characteristics of the corrected mortality tables produced.  
Remark: It is worth mentioning that although this extrapolation over another time period may induce some 
instability issues in several regression contexts due to non-stationarity effects, we rely here on the fact that the 
selected regressors are ‘mirror’ countries which show similar error patterns (due to external and internal 
shocks), which are thus likely to reproduce the 1919-1920 effect (in between the Spanish flu and the end of the 
First World War). The illustrative results detailed in the next part indeed show the efficiency of the method to 
correct the 1919-1920 effects, while providing an underlying interpretation of the correction indicator dynamics 
based on ‘explanatory’ countries. At this stage, we argue that significant theoretical work remains to be done in 
this direction, which is out of scope of the present paper. 
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Figure 4 - Completion by regression of the correction indicator for West Germany 
 
2.4. Analysis of corrected mortality tables 
 
Let us denote by 𝐼(𝑏) the correction indicator for year of birth 𝑏. Then the corrected period mortality rates are 
constructed as 
?̃?(𝑥, 𝑡) =
𝑚(𝑥, 𝑡)
𝐼(𝑡 − 𝑥)
 
Then matrices of crude and corrected mortality improvement rates 𝑟(𝑥, 𝑡) or ?̃?(𝑥, 𝑡) can be analyzed and 
compared; mortality improvement rates are here defined as  
𝑟(𝑥, 𝑡) =
𝑚(𝑥, 𝑡 + 1)
𝑚(𝑥, 𝑡)
− 1 and ?̃?(𝑥, 𝑡) =
?̃?(𝑥, 𝑡 + 1)
?̃?(𝑥, 𝑡)
− 1. 
The data used to specify the crude death rates 𝑚(𝑥, 𝑡) by single year and one-year age bands were 
downloaded from the Human Mortality Database on September 1st 2015 for France (civil population), Italy (civil 
population) and West Germany (total population). 
 
Corrected mortality tables for France and Italy 
The matrices of crude and corrected mortality improvement rates by age and time are depicted in Figure 5. The 
matrices are centred on the 1919-1920 effects of interest, and the colour scale is fixed. The correction of these 
effects for France and Italy, and also the correction for France of the additional anomalies around years of birth 
1915 and 1940 can clearly be observed. Note that for all the three countries, we use both male and female 
corrected tables, although we represent that related to the total population as a purpose of illustration. 
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Figure 5 - Crude and corrected mortality improvements for France and Italy 
 
Corrected mortality tables for West Germany 
As stated in the previous part 2.3, the correction efficiency of the regression approach to reconstruct the 
correction indicator for West Germany is to be assessed by comparing the crude and corrected period mortality 
table. The results of the correction process are depicted on improvement rate matrices in Figure 6 for the two 
criteria selected (BIC or R-squared); from left to right: crude data, corrected data with BIC selection, corrected 
data with Adjusted R-squared selection.  
 
Figure 6 - From left to right: crude mortality improvements for West Germany, and the corrected versions according to 
the BIC and R-squared criteria 
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The correction process appears to be efficient concerning the 1919-1920 effects, which are the generations of 
interest in this paper. It should be noted that the 1915 effect is also clearly corrected, but additionally that the 
correction specific to year of birth 1945 correction is not fully performed. Although in our context, this is a 
second order issue as our main interest lies in the proper correction of the huge 1915 and 1920 anomalies, 
developing an improved correction method for such generations is left for further research. 
Recall that the retained criterion is R-squared for the reasons detailed in the previous part 2.3, including in 
particular the fact that the corrected table shows even less isolated cohort trends. 
Key characteristics of corrected historical mortality tables 
To focus on historical data without introducing any external effect, analyses of the following section are 
conducted on mortality data embedded in the historical data tables only. As such, life expectancy and mortality 
indicators are restricted to ages 30 and 95.  
While the method is applied on the entire mortality table, only specific generations are corrected and the main 
table characteristics are  preserved, as shown for the period life expectancy of each year in Figure 7.  
 
 
Figure 7 – Historical period life expectancy at age 30, truncated at age 95, before and after HFD correction 
The following section highlights that these artificial cohort effects are identifiable on basic quantities usually 
derived on crude mortality data, as the force of mortality and the death functions. 
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Period-based Forces of Mortality 
The analysis of the forces mortality of French woman reveals the transitory and specific volatility of generations 
born between 1918 to 1923 in the period based mortality tables of year 1964 to 2013.  
Figure 8 – Period force of mortality before and after HFD correction 
 
Death curves 
In mirror to the force of mortality, the next two graphs on Figure 9 present the death curves of France female 
population over the same 4 periods between years 1964 and 2009. It is noticeable how corrected tables 
increased the regularity of the death curves. Results are similar for all countries and gender in our study. 
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Figure 9 –Deaths curves, before and after HFD correction 
 
In summary to the past section, analytical data shows that the correction added to HMD data effectively 
removes artificial cohort effects around generations 1918 to 1923, while keeping main mortality 
characteristics. 
3. The impact of mortality data anomalies on an internal model 
 
This section details the impact of retreated national population exposure on several classical mortality models. 
In a first step, we present the evolution of the fit of each mortality model used (M1, M3 and M5) and in a 
second step the impact on projected life expectancy based on both input sets (HMD versus HMD + HFD). 
Finally, we discuss how the retreated mortality data influence the selection of the best actuarial model, the 
computation of the Solvency Capital Requirement, as well as on the stability of the longevity risk assessment. 
3.1. Internal model specification 
 
16 
 
The simplified prototype of internal model used for this analysis works as follows: a set of mortality models is 
fitted based on national population mortality data, an  the ‘best’ mo e  is se ecte  base  on both statistical 
and qualitative criteria. The selected mortality model is then used to draw simulated forecasts, and a 
prospective mortality table corresponding to the 99.5 percentile in terms of improvements is built. This allows 
to provide the longevity shock at the core of the Solvency II economic capital calculation, here based on an 
annuity product portfolio. Longevity risk can be divided in two different risk sources: a level component and a 
trend component, on which this article focuses on. 
The internal model process workflow is illustrated in Figure 10: the usual workflow is represented in grey, and 
the additional step of mortality tables correction is represented in red. Indeed, this correction process is 
directly performed on national population mortality tables, and is then used in the model calibration and 
selection processes.  
 
Figure 10 – The mortality table correction process within the Internal Model workflow 
 
The simplified prototype of internal model, employed here to assess longevity risk, relies on several classical 
stochastic mortality models, which we briefly describe in the following.  
The famous model by Lee and Carter (1992), also referred to as M1, decomposes mortality as a static age-
structure (𝛽𝑥
(1)), a general level driven by a stochastic process in time (𝜅𝑡
(2) ) and an age-specific sensitivity 
(𝛽𝑥
(2)) to this general level as follows: 
𝑙𝑜𝑔( 𝑚(𝑡, 𝑥) ) =  𝛽𝑥
(1)
+ 𝛽𝑥
(2)
𝜅𝑡
(2)
. 
In order to account for possible cohort effects, while relying on a reasonable parametrization, one can also 
consider the Age-Period-Cohort model (M3) as proposed in Currie (2006), which is a special case of  Renshaw & 
Haberman (2006), where the age, period and cohort components influence mortality independently in the 
following form: 
𝑙𝑜𝑔(𝑚(𝑡, 𝑥)) = 𝛽𝑥
(1)
+ 𝜅𝑡
(2)
+ 𝛾𝑡−𝑥
(3)
 , 
with 𝛾𝑐  the additional cohort-related factor which allows to adjust mortality rates for a ‘generation’ (or 
diagonal) which originates from year 𝑐 = 𝑡 − 𝑥 .  
 
As an alternative taking advantage of the log-linearity of mortality rates from intermediate ages, the CBD 
model from Cairns et al. (2006), known as M5, can also be tested: 
𝑙𝑜𝑔𝑖𝑡(𝑞(𝑥, 𝑡)) =  𝜅𝑡
(1)
+  𝜅𝑡
(2)
(𝑥 − ?̅?), 
where ?̅? denotes the mean age over the range of ages used in the calibration. 
 
 
 
To select the most adequate modelling to one set of historical mortality data, each model is calibrated 
independently in a first phase. Calibration results are compared in a second phase, putting emphasis on a set of 
necessary or wishful properties, for example: 
Input: 
national 
mortality 
tables
Mortality 
tables 
correction 
process
Model 
calibration and 
selection
Simulation of 
future 
scenarios
Shock 
calculation 
from quantile 
Calculation of 
Solvency 
Capital 
Requirement
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• Quality of fit (BIC criterion) of historical mortality tables, 
• Randomness of standardized residuals, 
• Stability of model parameters to the age-band and historical-length of mortality data used for 
calibration, 
• Back-test of projected mortality improvements against historical improvements. 
 
For further discussion regarding interesting properties and tests for model selection, the reader is referred to 
e.g. Cairns et al. (2009). Calibration results will be discussed in the next section. 
 
Let us recall that the data used to specify the crude death rates 𝑚(𝑥, 𝑡) by single year and one-year age bands 
were downloaded from the Human Mortality Database on September 1st 2015 for France (civil population), 
Italy (civil population) and West Germany (total population). As for calibration purposes, the datasets are 
restricted to the most recent decades of historic, retaining an age-band characteristic for a standard insured 
population. Mortality at higher ages than the maximum of the age band is commonly assessed based on a table 
closure technique. References and discussions on table closure methodologies can be found in Quashie and 
Denuit (2005). 
 
3.2. Model fitting 
 
For the purpose of illustration, we restrict our graphical analysis to France only, as results are very similar for 
Italy and Germany. Any specific outcome for Italy or Germany will be mentioned. 
M1 model 
The M1 model solely captures age-related and period related mortality effects. As the retreated exposures 
mostly correct cohort based effects, one could expect limited impacts on the M1 model components. As a 
matter of fact, differences of fit results on separate model components are very moderate, as illustrated below 
for the French female population. 
Results shown on Figure 11 are similar for both genders and all countries in our study. 
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Figure 11 – Lee-Carter model (M1) components fitting 
 
M3 model 
In addition to age-related (beta) and period related (kappa) mortality effects, the M3 model also captures 
specific cohort effects between generations (gamma). We observe that the gamma component shows an 
improved stability on the specific generations related to shocks in birth patterns around the two World Wars, 
whereas the beta component (age-related) and kappa component (period related) show no sensible changes. 
Changes in the separate model components are restricted to specific generations of the cohort-effect 
component only. 
Female and Male populations of each country in our study show similar results to the French female population 
illustrated below  in Figure 12. 
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Figure 12 – Age-Period-Cohort model (M3) components fitting 
 
M5 model 
The M5 model solely captures age related and period related mortality effects. In our test, it proved to be very 
stable against the new retreated HMD + HFD tables for both gender in each country of our study (see Figure 
13). 
 
 
Figure 13 – Cairns-Blake-Dowd model (M5) components fitting 
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3.3. Impact on future Life expectancy 
 
In this section, we propose to highlight potential changes on Life expectancy through two complementary 
approaches. On the one hand, projected period mortality tables are compared with and without exposure 
retreatment on the basis of residual period life expectancy at age 30 and truncated at age 95. On the other 
hand, cohort mortality tables are compared with and without exposure retreatment for all active generations 
being of age 30 to 95 years in 2015. Figures present the outcome of the models stochastic projection and 
differences between life expectancies for the median (baseline), 0.5th percentile (mortality shock) and 99.5th 
percentile (longevity shock) scenarios. 
 
M1 model 
As it was expected based on the reduced impact on the fit of M1 model component, Life expectancy analysis 
show very limited change between both set of popu ation’s exposure  ata, as depicted in Figure 14. For both 
genders and for each country in our study, period-based life expectancy between age 30 and 95 as well as live 
generation life expectancy do not vary more than half a month. 
 
Figure 14 – Period and Cohort life expectancy as of 2015 for French females, M1 model 
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M3 model 
Detailing the impact on the M3 model calibration, we observe that the projected life expectancy (period-based) 
is very stable. Cohort Life expectancy show limited variations, with highest impact located during World War II. 
 
Figure 15 – Period and Cohort life expectancy as of 2015 for French females, M3 model 
 
M5 model 
Turning to the M5 model, as the stability between the fits of the model components led to think, the retreated 
exposure data have no material impact on period life expectancy and on cohort life expectancy (see Figure 16). 
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Figure 16 – Period and Cohort life expectancy as of 2015 for French females, M5 model 
 
Conclusion 
In a nutshell, the study of the model fits on historical tables shows that M1 and M5 models are almost not 
impacted by the cohort-effect retreatment, due to the models not capturing the cohort effect. M3 model is not 
significantly impacted by the corrected exposure tables as both period and cohort-based life expectancy keep 
the same level. However, cohort Life expectancy shows evidences of change in the inter-generational structure, 
and the volatility is reduced in the model calibrated with HMD with HFD correction (see again Figure 12). 
 
3.4. Model selection process 
 
As far as the model selection process is concerned, in all cases of our study, the improved BIC criterion as 
depicted in Figure 17 shows that the retreated exposure allows M1 and M5 model to better capture mortality 
dynamics embedded in HMD table. BIC criterion does not show a measurable change for the M3. Finally, for 
several populations as for Italian female table, retreated exposures allow for M1 to achieve a higher BIC level 
than the M3 model. 
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As highlighted in the former section, the retreatment of the exposure reduces fluctuations of the component 
related to the cohort-effect. Therefore, models that do not take cohort-effect into account improve their 
efficiency to fit historical mortality data; models that capture cohort-effect also benefit from an improved 
stability (less fluctuation). 
 
Figure 17 – BIC criteria for model calibration 
 
3.5. Solvency Capital Requirement 
 
The trend component of the longevity SCR (ca  e  “SCR” in the fo  owing paragraphs) is here given as a change 
of future mortality improvements. The model described previously gives a full distribution of mortality 
improvement rate by gender, age and year. The most adverse scenario corresponds to the 0.5th percentile of 
the distribution of longevity improvements, denoted 𝐼𝑅𝑥,𝑡0→𝑡
𝑆𝐶𝑅 . To obtain the final mortality table for SCR 
calculations, the improvements of the Best Estimate assumptions 
𝐼𝑅𝑥,𝑡0→𝑡
𝐵𝐸 =
𝑞𝑥,𝑡
𝐵𝐸−𝑞𝑥,𝑡0
𝐵𝐸
𝑞𝑥,𝑡0
𝐵𝐸 , 𝑓𝑜𝑟 𝑡 > 𝑡0, 
are replaced by the ones obtained from the model mentioned above for all years from the valuation year t0 
onwards. The initial mortality rates of the trend SCR component for year 𝑡0 do not change from the Best 
Estimate mortality rates for this same year. For future years 𝑡 > 𝑡0, the mortality rates are defined as follows 
for the Best Estimate (𝑞𝑥,𝑡
𝐵𝐸) and the SCR (𝑞𝑥,𝑡
𝑆𝐶𝑅) respectively: 
𝑞𝑥,𝑡
𝐵𝐸 = 𝑞𝑥,𝑡0
𝐵𝐸 ∙ (1 + 𝐼𝑅𝑥,𝑡0→𝑡
𝐵𝐸 ), 
𝑞𝑥,𝑡
𝑆𝐶𝑅 = 𝑞𝑥,𝑡0
𝐵𝐸 ∙ (1 + 𝐼𝑅𝑥,𝑡0→𝑡
𝑆𝐶𝑅 ). 
We depict on Figure 18 the impact on mortality rate scenarios of the change of data source (HMD data with 
HFD correction). As the improvements distribution is changed with the data correction, we observe on Figure 
18 a slight impact on mortality rates due to lower cohort effects, as stated previously during the calibration of 
mortality models. Note that both the base ine scenario (“Base”) an  the SCR scenario are changed in this 
figure. 
HMD HMD+HFD Abs. di ff. HMD HMD+HFD Abs. di ff.
M1 -13 585 -11 907 -12% M1 -16 767 -15 128 -10%
M3 -12 625 -12 625 0% M3 -13 627 -13 627 0%
M5 -160 771 -159 199 -1% M5 -72 421 -70 805 -2%
HMD HMD+HFD % di ff. HMD HMD+HFD % di ff.
M1 -14 217 -12 427 -13% M1 -18 117 -16 216 -10%
M3 -13 596 -13 596 0% M3 -15 026 -15 026 0%
M5 -65 430 -63 734 -3% M5 -29 882 -27 939 -7%
HMD HMD+HFD % di ff. HMD HMD+HFD % di ff.
M1 -16 410 -13 360 -19% M1 -16 363 -14 318 -13%
M3 -13 478 -13 478 0% M3 -12 959 -12 959 0%
M5 -99 971 -96 901 -3% M5 -28 060 -25 971 -7%
Germany 
Males
BIC cri terion
France 
Males
BIC cri terion
Ita ly 
Females
BIC cri terion Ita ly 
Males
BIC cri terion
Germany 
Females
BIC cri terion
France 
Females
BIC cri terion
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Figure 18 – Baseline and Longevity Trend SCR future mortality for French females born in 1955 
 
As stated previously, there is less volatility in mortality assumptions when using the HFD correction. The level 
of mortality rates is however not impacted. The Best Estimate used are already without this excess of volatility, 
therefore in the following analysis we will focus only at the impact on SCR from changing the HMD data with 
HFD-corrected data while keeping the same Best Estimate assumptions. 
This decrease of captured volatility in the SCR scenario can be seen for various different cohorts. This can be 
illustrated with the impact of Longevity Trend SCR on the evolution of the cohort life expectancy. The cohort 
life expectancy including future mortality improvements is defined as follows for 𝐴 ∈ {𝐵𝐸, 𝑆𝐶𝑅}: 
𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝐴) = ∑ ∏(1 − 𝑞𝑥+𝑖,𝑡+𝑖
𝐴 )
𝑘−1
𝑖=0
∞
𝑘=1
. 
The impact on cohort life expectancy from replacing the Best Estimate improvements by the SCR 
improvements is defined as follows: 
𝐼𝐸𝑥,𝑡 =
𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝑆𝐶𝑅) − 𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝐵𝐸)
𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝐵𝐸)
. 
The impact is illustrated on Figure 19 for French females in 2015 born between 1925 and 1975, when having on 
one hand the Best Estimate assumptions with the improvement remaining the same, and on the other 
mortality rates using Longevity SCR improvements. For the later, we perform the calculations with the data 
from HMD only, and with the HMD data corrected with the HFD data. 
With the change of data we observe a lower volatility on the indicator 𝐼𝐸𝑥,𝑡 for some cohorts, notably females 
being born in the early 1940’s during World War II, i.e. being between 70 and 75 in 2015. There is a small 
difference for older people (those being born between the World Wars) and almost no difference for those 
being born after 1945.  
 
0%
5%
10%
15%
20%
60 70 80 90 100
M
o
rt
al
it
y 
ra
te
Age
Mortality rates - French females born in 1955
Base - HMD Base - HMD+HFD SCR - HMD SCR - HMD+HFD
25 
 
 
Figure 19 – Longevity SCR impact on Cohort Life Expectancy in 2015 for French females born between 1925 and 1975 
 
In order to compute the final impact, the portfolios used for the study are originated from the three countries 
France, Germany and Italy, including various products. For France, it is a savings and retirement business made 
of individual and group products, with on the in-force an average age around 65/70 for the annuity phase. For 
Germany these are individual investment & savings products, with an average age of policyholders around 47. 
For Italy the products are investment & savings products (62%) and long-term care products (38%) exposed to 
longevity risk. The savings and retirement businesses for these three countries are a mix of General Account, 
with various guaranteed rates, and Unit-Linked products for the accumulation phase. Long-term care are a pure 
General Account products. 
Using the full Internal Model methodology and the aggregation with other risks, with on one hand the HMD 
data and on the other hand the HMD data corrected with HFD, we observe that the correction leads to a small 
reduction of Longevity SCR (Figure 20). 
 
Figure 20 – Impact on Longevity Trend SCR 
This negative impact is consistent with the results found previously on indicator 𝐼𝐸𝑥,𝑡: the removal of non-
necessary volatility on several cohorts lead to a decrease of the Longevity SCR. This is even clearer for the 
French portfolio, when compared to the German and Italian portfolios, as the French portfolio contains more 
annuitants close to ages 70-75 at which the reduction of non-necessary volatility is the strongest. 
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Looking now at the total Life SCR of each of these entities with the other risks and the diversification between 
these risks calculated with an Internal Model methodology, the impacts on total Life SCR are negative but 
almost non-significant (Figure 21) even as Longevity STEC roughly represents 20% Life STEC pre-diversification. 
 
Figure 21 – Impact on Life SCR 
Even if the quantitative impacts are very moderate, the treatment of HMD data with the HFD database has a 
positive effect on the data quality and therefore on the longevity risk assessment due to a lower volatility in 
future mortality assumptions. 
 
3.6. Stability of the longevity risk assessment 
 
The stability from a year to another of the longevity risk assessment can be roughly estimated by looking at the 
evolution of the impact of Longevity Trend SCR mortality improvements on the cohort life expectancy of the 
portfolio, i.e. the difference for a policyholder at age 𝑥 in year 𝑡: 
𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝑆𝐶𝑅) − 𝑒𝑥,𝑡
𝐶𝑜ℎ𝑜𝑟𝑡(𝐵𝐸) 
and its evolution between t and t+1. This indicator is calculated on the whole portfolio mix. There again, the 
Best Estimate does not change but SCR mortality improvements change as we consider the improvements 
calibrated with HMD data, and also the improvements calibrated with HMD retreated with HFD data. 
As shown in Figure 22, the retreatment brings a more stable longevity risk assessment between 2015 and 2016 
for France and Italy but not for Germany, notably due to women. Overall, the volatility of Longevity SCR shock 
over time decreases. 
 
Figure 22 – Evolution of Cohort Life Expectancy gap between baseline and Longevity SCR Trend between 2015 and 2016 
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4. Concluding remarks 
 
To illustrate it with a caricature, even if an internal model is the most robust one from a technical standpoint, is 
perfectly adapted to the inherent risks of a company, the “garbage in, garbage out” effect has to be avoi e . In 
a global context of increasing regulatory needs, particularly on the data quality, using such a methodology to 
improve the data of external providers, as it is the case for the Human Mortality Database, is key. This database 
is regarded as a reference on the insurance market to have national mortality data on a large scope of 
countries, with similar demographic methodologies used from one country to another. Implementing the 
described methodology to correct data anomalies can therefore help the insurance market. 
Risks are consequently better captured, assessed and monitored. The conclusion of the study and the practical 
application show that the longevity assessment remains stable as the global impact is non-significant on the 
tested portfolios but indicators are improved; with a better data quality the volatility coming from these 
exceptional cohort, effects is lowered, here slightly decreasing the capital requirement. 
This kind of database cleansing is obviously welcomed and can help demographers and actuaries to better 
monitor longevity and mortality risks. In the future, it is important to continue tracking and correcting other 
kinds of errors that can be included in the current mortality tables.  
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